Bortezomib plus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 Trial.

著者: B Coiffier, E.A. Osmanov, Xin Hong, Adriana Scheliga, Jiřı́ Mayer, F. Offner, Simon Rule, Adriana Teixeira, Jan Walewski, Shoko Vos, Michael Crump, Ofer Shpilberg, DL Esseltine, E. Zhu, Christopher Enny, Panteli Theocharous, Helgi van de Velde, Y. A. Elsayed, Pier Luigi Zinzani, Lym study investigators, Marina. Liberati Anna - The Lancet 2011 被引用: 1,626